Metabolic Diseases
Interconnected cardiovascular, renal, and metabolic (CRM) diseases are the leading cause of death worldwide and account for up to 20 million deaths annually. By following the science, we are targeting specific pathways to address the interconnected nature of these diseases. Building on our expertise in developing innovative treatments for CRM conditions, our goal is to improve the lives of people living with these diseases, their families and the healthcare system.
Boehringer’s Commitment to Metabolic Diseases
Metabolic Diseases
Positioning in Cardiovascular, Renal and Metabolic Diseases
Our mission is to protect people from the consequences of cardiovascular, renal and metabolic diseases, and advocate for a shift from fragmented to integrated solutions that focus on prevention and treatment.
Metabolic Diseases
Partnering in Cardiovascular, Renal and Metabolic Diseases
Our commitment to collaboration with science-driven partners and academia is driven by our ambition to help change the future for people living with cardiovascular, renal and metabolic diseases
Metabolic Diseases
Innovation in Cardio-Renal-Metabolic Diseases
Cardiovascular, renal and metabolic diseases are connected conditions that can amplify each other. We are dedicated to delivering innovation for people living with these diseases both now, and for future generations.
Downloads
Read more
Opens in new tabCardiovascular, renal, and metabolic conditions infographic
Learn more about the Cardiovascular, renal, and metabolic conditions infographic.
Latest News on Metabolic Diseases
February 26, 2024
Survodutide Phase II trial shows groundbreaking results in liver disease due to MASH, with significant improvements in fibrosis
December 11, 2023